Brief: Foghorn Therapeutics Q1 EPS USD -0.59
06/05/2024 12:00
May 06 (Reuters) - Foghorn Therapeutics Q1 net income USD -25.016 million. * Q1 collaboration revenue USD 5.05 million
FHTX — Foghorn Therapeutics News Story
0.000.00%
Last trade - 00:00- $118.77m
- -$48.81m
- $30.91m